Progress in KRAS Research

Research on inhibiting KRAS-driven cancers has seen increased enthusiasm over the past several years. Scientists are more hopeful than ever that an effective treatment can be found to improve the quality of life and outcomes for those diagnosed with KRAS-mutant cancers. Progress toward innovative solutions aimed at treating these cancers is happening on many fronts. In addition to the efforts of this Dream Team, the National Cancer Institute is making strides with its RAS Initiative.

The Dream Team has many exciting projects aimed at revolutionizing the treatment options for patients with KRAS-mutant non-small cell lung cancer (NSCLC). These studies involve: